Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...
Footwear retailer HOKA is taking over Bondi Beach this weekend, with a large-scale activation to launch its newest shoe, the Bondi 9, via Emotive. The North Bondi Surf Life Saving Club has been ...
Abstract: Currently, many researchers aim to achieve automatic depression level prediction via speech and video behavior analysis ... In response to the above issues, we propose a depression scale ...
The study found that after a month, 22.5 percent of patients taking the treatment showed improvements on the Montgomery-Asberg Depression Rating Scale, compared with 7.6 percent of patients taking ...